Enhancement of mast cell survival: A novel function of some secretory phospholipase A2 isotypes

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4161-4171

  Fonteh, A N ^a   Marion, C R ^a   Barham, B J ^a   Edens, M B ^a   Atsumi, G I ^a   Samet, J M ^a   High, K P ^a   Chilton, F H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DNA FRAGMENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; PHOSPHOLIPASE A2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME RELEASE; HYDROLYSIS; MAST CELL; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0035887918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4161     Document Type: Article

References (89)

1. Mast-cell-leukocyte cytokine cascades in allergic inflammation
2. Mast cell cytokines in allergy and inflammation
3. Lipid mediators of the allergic reaction
4. Mast cells as a source of multifunctional cytokines
5. Mast cells
6. Reversible expansion of primate mast cell populations in vivo by stem cell factor
7. A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis
8. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor
9. Effects of stem cell factor (kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone-marrow-derived or serosal mast cells
10. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis
11. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: Prevention of apoptosis by c-kit ligand
12. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of white spotting and steel mutant mice
13. Role for interleukin-3 in mast cell and basophil development and in immunity to parasites
14. The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis
15. Mast cell ontogeny and apoptosis
16. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor
17. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro
18. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro
19. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor
20. Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Racl and JNK activation in mast cell proliferation
21. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcεRI: Rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells
22. Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia
23. rus-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2
24. L
25. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-I and induces apoptosis
26. Mast cell apoptosis: From the DNA to the bedside
27. Activated Ha-ras induces apoptosis by association with phosphorylated Bcl-2 in a mitogen-activated protein kinase-independent manner
28. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase
29. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
30. p53 is not required for regulation of apoptosis or radioprotection by interleukin-3
31. Lipid metabolism and APC: Implications for colorectal cancer prevention
32. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells
33. Polyunsaturated fatty acids and colon cancer
34. Chemoprevention of colon cancer by dietary fatty acids
35. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells
36. 2 during apoptosis
37. 2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis
38. 2 by caspase-(ICE) and caspase-8 (FLICE)
39. 2 causes TNF resistance in human leukemic cells
40. 2 levels in murine mast cells by recombinant stem cell factor
41. 2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients
42. 2 gene is a candidate for the Mom 1 locus, a major modifier of ApcMin-induced intestinal neoplasia
43. 2 by C-reactive protein in vitro
44. 2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase
45. 2: A putative mediator of airway inflammation
46. 2: Role in physiologic and inflammatory processes
47. 2 expression and inflammation: The relationship with associated disease states
48. 2
49. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells
50. A rapid method of total lipid extraction and purification
51. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes
52. Quantitative measurement of Stachybotrys chartarum conidia using real time detection of PCR products with the TaqMan(TM) fluorogenic probe system
53. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
54. 2 in murine bone marrow-derived mast cells
55. 2-induced inflammation
56. 2
57. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils
58. Control of IκBα proteolysis by site-specific signal-induced phosphorylation
59. Akt-dependent cytokine production in mast cells
60. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
61. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity
62. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
63. IFNα/β promotes cell survival by activating NF-κB
64. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB
65. Novel inhibitors of cytokine-induced 1κBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
66. 2 generates anti-apoptotic survival signals in kidney fibroblasts
67. 2
68. 2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity
69. Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells
70. The role of disulfide-linked dimerization in interleukin-3 receptor signaling and biological activity
71. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response
72. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and anti-apoptosis
73. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
74. Relationship between arachidonate-phospholipid remodeling and apoptosis
75. Selective killing of human cancer cells by polyunsaturated fatty acids
76. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: Relationship to peroxides and vitamin-E
77. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism
78. 2 to liberate arachidonic acid
79. 2 induce β-glucuronidase release and IL-6 production from human lung macrophages
80. 2 during septic shock
81. 2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis
82. Antigen-induced generation of lyso-phospholipids in human airways
83. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics
84. 2 and distal prostaglandin synthase
85. 2 are activated during TNF priming of human neutrophils
86. 2
87. 4 release
88. 2 with homology to the group III bee venom enzyme
89. 2s preferentially expressed in type 2 helper T cells